Company Search:
Advanced Search
Sponsored Links
Clinuvel Pharmaceuticals Limited - ADR Company Snapshot
Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other companies in this sector in the United States: Crispr Therapeutics AG (2016 sales of $5.16 million ), bluebird bio Inc ($6.16 million of which 100% was Biological Products), and Regenxbio Inc ($4.59 million of which 100% was Biotechnology).

Sales Analysis. During the year ended June of 2016, sales at Clinuvel Pharmaceuticals Limited were $5.11 million. This is an increase of 68.5% versus 2015, when the company's sales were $3.03 million.
  Stock Performance Chart for Clinuvel Pharmaceuticals Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 5.20
(Figures in U.S. Dollars)
1 Week 0.4%   13 Weeks 3.0%  
4 Weeks 1.2%   52 Weeks 42.5%  
Clinuvel Pharmaceuticals Limited - ADR Key Data:
  Ticker: CLVLY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 5,110,475
(Year Ending Jan 2017).
Employees: 16
  Currency: U.S. Dollars Market Cap: 248,171,180
  Fiscal Yr Ends: June Shares Outstanding: 47,725,227
  Share Type: Ordinary Closely Held Shares: 10,283,776
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.